D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl]...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/234

A61K 31/425 (2006.01)

Patent

CA 1313139

PATENT PC 7301 dl-5-[(2-BENZYL-3,4-DIHYDRO-2H-BENZOPYRAN- 6-YL)METHYL]THIAZOLIDINE-2,4-DIONE AS AN ANTI-ATHEROSCLEROSIS AGENT. Abstract This invention relates of the use of a certain thiazolidine-2,4-dione, namely, dl-5-[(2-benzyl-3,4- dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4- dione, or a pharmaceutically acceptable cationic salt thereof, for retarding the development of arterial disease in mammals. More specifically, it relates to a method for reducing the serum cholesterol levels in mammals by administering to said mammals dl-5-[(2- benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]- thiazolidine-2,4-dione or a pharmaceutically acceptable cationic salt thereof.

584530

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl]... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl]..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl]... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1281923

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.